文献速递生殖医学

滋养外胚层活检降低早期妊娠血清β-人绒毛膜促性腺激素水平

Trophectoderm biopsy reduces the level of serum β-human chorionic gonadotropin in early pregnancy.
PubMed 文献 · Fertil Steril · 2020-07-31

回顾性队列研究纳入接受胚胎植入前遗传学检测(PGT)的383例女性共396个冻融胚胎移植(FET)周期,以及接受体外受精或卵胞浆内单精子注射的353例女性共465个FET周期,所有女性在囊胚移植后第12天血清β-hCG阳性。活检组临床妊娠者平均血清β-hCG为703.10(569.63),显著低于对照组的809.20(582.00)。两组围产结局包括胎龄、妊娠期高血压疾病和新生儿畸形无统计学显著差异。

要点

  • 滋养外胚层活检可能降低胚胎移植后第12天血清β-hCG水平。
  • 活检组预测活产的β-hCG阈值为368.55 mIU/mL,低于对照组的411.45 mIU/mL。
  • 两组围产结局包括胎龄、妊娠期高血压疾病和新生儿畸形无统计学显著差异。

核心结论

  • 滋养外胚层活检可能降低早期妊娠(胚胎移植后第12天)血清β-hCG水平,但未发现活检后不良围产结局风险增加。

研究设计与样本

  • 回顾性队列研究,在大学附属生殖医学中心进行。
  • 纳入接受PGT的383例女性共396个FET周期,以及接受体外受精或卵胞浆内单精子注射的353例女性共465个FET周期,所有女性在囊胚移植后第12天血清β-hCG阳性。

主要发现

  • 活检组临床妊娠者平均血清β-hCG为703.10(569.63),显著低于对照组的809.20(582.00)。
  • 两组围产结局包括胎龄、妊娠期高血压疾病和新生儿畸形无统计学显著差异。

关键数值与推荐

  • 对照组胚胎移植后第12天血清β-hCG预测活产的诊断阈值为411.45 mIU/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether trophectoderm biopsy has any impact on the level of serum β-human chorionic gonadotropin (β-hCG) in early pregnancies. DESIGN: Retrospective cohort study. SETTING: University-affiliated reproductive medical center. PATIENT(S): Three hundred and eighty-three women undergoing 396 frozen embryo transfer (FET) cycles with preimplantation genetic testing (PGT), and 353 women undergoing 465 FET cycles with in vitro fertilization or intracytoplasmic sperm injection, all women having positive serum β-hCG results on the 12th day after blastocysts transfers. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum β-hCG levels on the 12th day after warmed blastocyst transfer and perinatal outcomes of clinical pregnancy. RESULTS: The diagnostic threshold of serum β-hCG levels on the 12th day after FET for prediction of a live birth was 368.55 mIU/mL with an area under the curve of 0.791 (0.729∼0.853) in the biopsy group, which was lower than the 411.45 mIU/mL in the control group. The average level of serum β-hCG in the biopsy group with clinical pregnancies was statistically significantly lower than that of the control group: 703.10 (569.63) versus 809.20 (582.00), respectively. No statistically significant differences in perinatal outcomes, including gestational age, hypertensive disorder in pregnancy, and neonatal malformation, were found between the two groups. CONCLUSION(S): Trophectoderm biopsy may reduce the level of serum β-hCG in early pregnancies (the 12th day after embryo transfer), but no increased risk was found of adverse perinatal outcomes after trophectoderm biopsy.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Lu MM, Wen YX, Liu YL, et al. Trophectoderm biopsy reduces the level of serum β-human chorionic gonadotropin in early pregnancy. Fertil Steril. 2020. PMID: 32741620. doi:10.1016/j.fertnstert.2020.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。